A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults
Source
Human vaccines & immunotherapeutics - ISSN 2164-5515-22:1 (2026) p. 1-19
Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine : a randomised, placebo-controlled, first-in-human trial
Source
The lancet : international edition - ISSN 0140-6736-401:10384 (2023) p. 1267-1276
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study
Source
Vaccine - ISSN 0264-410X-41:10 (2023) p. 1657-1667
Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine : intramuscular results
Source
The journal of infectious diseases - ISSN 0022-1899-226:1 (2022) p. 119-127
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults : two clinical trials
Source
The lancet : international edition - ISSN 0140-6736-397:10268 (2021) p. 39-50